Financial hardships experienced by cancer survivors: A systematic review

Journal of the National Cancer Institute

Volumn 109, Issue 2, 2017, Pages

  Altice, Cheryl K ^a   Banegas, Matthew P ^b   Tucker Seeley, Reginald D ^c,d   Yabroff, K Robin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CANCER SURVIVOR; CINAHL; COPING BEHAVIOR; DISTRESS SYNDROME; DRUG COST; EMBASE; FINANCIAL DEFICIT; FINANCIAL MANAGEMENT; HUMAN; MEDLINE; PATIENT WORRY; PERSONAL EXPERIENCE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCOPUS; SYSTEMATIC REVIEW; COST OF ILLNESS; ECONOMICS; FEE; MEDICATION COMPLIANCE; NEOPLASM; PRODUCTIVITY; PSYCHOLOGY; SURVIVOR; UNITED STATES;

COST OF ILLNESS; EFFICIENCY; FEES AND CHARGES; HUMANS; MEDICATION ADHERENCE; NEOPLASMS; SURVIVORS; UNITED STATES;

EID: 85015696500     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djw205     Document Type: Review

References (83)

1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013. http://seer.cancer.gov/csr/1975-2013/. Accessed September 30, 2015.
2. de Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: Prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561-570.
3. Conti RM, Fein AJ, Bhatta SS. National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011. Health Aff (Millwood). 2014;33(10):1721-1727.
4. Bradley CJ, Yabroff KR, Warren JL, et al. Trends in the treatment of metastatic colon and rectal cancer in elderly patients. Med Care. 2016;54(5):490-497.
5. Shih YC, Smieliauskas F, Geynisman DM, et al. Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol. 2015;33(19):2190-2196.
6. Guy GP Jr, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749-3757.
7. Ekwueme DU, Yabroff KR, Guy GP Jr, et al. Medical costs and productivity losses of cancer survivors-United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63(23):505-510.
8. Jagsi R, Pottow JA, Griffith KA, et al. Long-term financial burden of breast cancer: Experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269-1276.
9. Meneses K, Azuero A, Hassey L, et al. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol. 2012;124(3):437-443.
10. Bestvina CM, Zullig LL, Rushing C, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014;10(3): 162-167.
11. US Department of Health and Human Services Office of Disease Prevention and Health Promotion. Healthy people 2020. https://www.healthypeople. gov/2020/topics-objectives/topic/cancer/objectives. Accessed June 10, 2015.
12. Ramsey S, Blough D, Kirchhoff A, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32(6):1143-1152.
13. Schwartz K, Claxton G, Martin K, et al. Spending to Survive: Cancer Patients Confront Holes in the Health Insurance System. Menlo Park, CA: Kaiser Family Foundation; 2009.
14. Kent EE, Forsythe LP, Yabroff KR, et al. Are survivors who report cancerrelated financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710-3717.
15. Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9): 980-986.
16. Zafar SY. Financial toxicity of cancer care: It's time to intervene. J Natl Cancer Inst. 2016;108(5).
17. Banegas MP, Guy GP Jr, de Moor JS, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54-61.
18. Yabroff KR, Dowling EC, Guy GP Jr, et al. Financial hardship associated with cancer in the united states: Findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259-267.
19. Hanratty B, Holland P, Jacoby A, et al. Financial stress and strain associatedwith terminal cancer-a review of the evidence. PalliatMed. 2007;21(7):595-607.
20. de Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer. 2014;120(20): 3245-3253.
21. Choi SK, Adams SA, Eberth JM, et al. Medicaid coverage expansion and implications for cancer disparities. Am J Public Health. 2015;105(suppl 5):S706-S712.
22. Tucker-Seeley RD, Yabroff KR. Minimizing the "financial toxicity" associated with cancer care: Advancing the research agenda. J Natl Cancer Inst. 2016; 108(5).
23. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381-390.
24. Martin MY, Fouad MN, Oster RA, et al. What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups. Support Care Cancer. 2014;22(1):233-244.
25. Meropol NJ, Schulman KA. Cost of cancer care: Issues and implications. J Clin Oncol. 2007;25(2):180-186.
26. de Souza JA, Yap B, Ratain MJ, et al. User beware: We need more science and less art when measuring financial toxicity in oncology. J Clin Oncol. 2015; 33(12):1414-1415.
27. Lazarus R, Folkman S. The concept of coping. In Stress, Appraisal and Coping. New York: Springer Publishing Company; 1984:117-140.
28. Arozullah AM, Calhoun EA, Wolf M, et al. The financial burden of cancer: Estimates from a study of insured women with breast cancer. J Support Oncol. 2004;2(3):271-278.
29. Banthin JS, Bernard DM. Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003. JAMA. 2006;296(22):2712-2719.
30. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821-2826.
31. Cagle JG, Carr DC, Hong S, et al. Financial burden among US households affected by cancer at the end of life. Psychooncology. 2016;25(8):919-926.
32. Chang S, Long SR, Kutikova L, et al. Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004;22(17):3524-3530.
33. Chino F, Peppercorn J, Taylor DH Jr, et al. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014;19(4): 414-420.
34. Chirikos TN, Russell-Jacobs A, Cantor AB. Indirect economic effects of longterm breast cancer survival. Cancer Pract. 2002;10(5):248-255.
35. Davidoff AJ, Erten M, Shaffer T, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6): 1257-1265.
36. Davidoff AJ, Hill SC, Bernard D, et al. The Affordable Care Act and expanded insurance eligibility among nonelderly adult cancer survivors. J Natl Cancer Inst. 2015;107(9).
37. Dowling EC, Chawla N, Forsythe LP, et al. Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer. 2013;119(18):3393-3401.
38. Ell K, Xie B, Wells A, et al. Economic stress among low-income women with cancer: Effects on quality of life. Cancer. 2008;112(3):616-625.
39. Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of cancer on survivors' quality of life. J Oncol Pract. 2014;10(5):332-338.
40. Finkelstein EA, Tangka FK, Trogdon JG, et al. The personal financial burden of cancer for the working-aged population. Am J Manag Care. 2009;15(11): 801-806.
41. Guy GP, Robin Yabroff K, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Affairs. 2014;33(6):1024-1031.
42. Guy GP Jr, Yabroff KR, Ekwueme DU, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012. Am J Prev Med. 2015;49(6 suppl 5):S489-S497.
43. Huntington SF, Weiss BM, Vogl DT, et al. Financial toxicity in insured patients with multiple myeloma: A cross-sectional pilot study. Lancet Haematol. 2015; 2(10):e408-e416.
44. Irwin B, Kimmick G, Altomare I, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19(11):1135-1140.
45. Jacobson JJ, Epstein JB, Eichmiller FC, et al. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: Commercial insurance, Medicare, and Medicaid. Head Neck Oncol. 2012;4:15.
46. Jayadevappa R, Schwartz JS, Chhatre S, et al. The burden of out-of-pocket and indirect costs of prostate cancer. Prostate. 2010;70(11):1255-1264.
47. Kilgore ML, Goldman DP. Drug costs and out-of-pocket spending in cancer clinical trials. Contemp Clin Trials. 2008;29(1):1-8.
48. Langa KM, Fendrick AM, Chernew ME, et al. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health. 2004;7(2):186-194.
49. Li C, Li C, Forsythe L, et al. Mental health services utilization and expenditures associated with cancer survivorship in the United States. J Cancer Surviv. 2015;9(1):50-58.
50. Meisenberg BR, Varner A, Ellis E, et al. Patient attitudes regarding the cost of illness in cancer care. Oncologist. 2015;20(10):1199-1204.
51. Moore K. Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncol Nurs Forum. 1998;25(9):1615-1622.
52. Pisu M, Azuero A, Meneses K, et al. Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI). Breast Cancer Res Treat. 2011;127(2):521-529.
53. Pisu M, Kenzik KM, Oster RA, et al. Economic hardship of minority and nonminority cancer survivors 1 year after diagnosis: Another long-term effect of cancer? Cancer. 2015;121(8):1257-1264.
54. Regenbogen SE, Veenstra CM, Hawley ST, et al. The personal financial burden of complications after colorectal cancer surgery. Cancer. 2014;120(19): 3074-3081.
55. Sasser AC, Rousculp MD, Birnbaum HG, et al. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues. 2005;15(3):97-108.
56. Shankaran V, Jolly S, Blough D, et al. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol. 2012;30(14): 1608-1614.
57. Teitelbaum A, Ba-Mancini A, Huang H, et al. Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: Findings using realworld claims data. Oncologist. 2013;18(1):37-45.
58. Veenstra CM, Regenbogen SE, Hawley ST, et al. A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care. 2014;52(11):957-962.
59. Wan Y, Gao X, Mehta S, et al. Indirect costs associated with metastatic breast cancer. J Med Econ. 2013;16(10):1169-1178.
60. Yabroff KR, Davis WW, Lamont EB, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007;99(1):14-23.
61. Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors: Findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322-1330.
62. Yabroff KR, Warren JL, Knopf K, et al. Estimating patient time costs associated with colorectal cancer care. Med Care. 2005;43(7):640-648.
63. Zafar SY, McNeil RB, Thomas CM, et al. Population-based assessment of cancer survivors' financial burden and quality of life: A prospective cohort study. J Oncol Pract. 2015;11(2):145-150.
64. Zullig LL, Peppercorn JM, Schrag D, et al. Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract. 2013;9(6 SUPPL.):60s-63s.
65. Prawitz AD, Garman ET, Sorhaindo B, et al. The incharge financial distress/financial well-being scale: Establishing validity and reliability. Fin Counsel Plan. 2006;17:34-50.
66. Dusetzina SB. Drug pricing trends for orally administered anticancer medications reimbursed by commercial health plans, 2000-2014. JAMA Oncol. 2016; 2(7):960-961.
67. Lee JA, Roehrig CS, Butto ED. Cancer care cost trends in the United States: 1998 to 2012. Cancer. 2016;122(7):1078-1084.
68. Tangka FK, Trogdon JG, Richardson LC, et al. Cancer treatment cost in the United States: Has the burden shifted over time? Cancer. 2010;116(14): 3477-3484.
69. American Society of Clinical Oncology. The state of cancer care in America, 2016: A report by the American Society of Clinical Oncology. J Oncol Pract. 2016;12(18): 339-339.
70. Kline RM, Bazell C, Smith E, et al. Centers for medicare and medicaid services: Using an episode-based payment model to improve oncology care. J Oncol Pract. 2015;11(2):114-116.
71. Newcomer LN. Innovative payment models and measurement for cancer therapy. J Oncol Pract. 2014;10(3):187-189.
72. Page RD, Newcomer LN, Sprandio JD, et al. The patient-centeredmedical home in oncology: From concept to reality. AmSoc Clin Oncol Educ Book. 2015;e82-e89.
73. Schnipper LE, Davidson NE, Wollins DS, et al. American Society of Clinical Oncology statement: A conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33(23):2563-2577.
74. Fluchel MN, Kirchhoff AC, Bodson J, et al. Geography and the burden of care in pediatric cancers. Pediatr Blood Cancer. 2014;61(11):1918-1924.
75. Given BA, Given CW, Stommel M. Family and out-of-pocket costs for women with breast cancer. Cancer Pract. 1994;2(3):187-193.
76. Van Houtven CH, Ramsey SD, Hornbrook MC, et al. Economic burden for informal caregivers of lung and colorectal cancer patients. Oncologist. 2010; 15(8):883-893.
77. Warner EL, Kirchhoff AC, Nam GE, et al. Financial burden of pediatric cancer for patients and their families. J Oncol Pract. 2015;11(1):12-18.
78. Li C, Zeliadt SB, Hall IJ, et al. Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: An economic perspective. Support Care Cancer. 2013;21(12):3461-3469.
79. Girgis A, Lambert S, Johnson C, et al. Physical, psychosocial, relationship, and economic burden of caring for people with cancer: A review. J Oncol Pract. 2013;9(4):197-202.
80. Lauzier S, Levesque P, Mondor M, et al. Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses. J Natl Cancer Inst. 2013;105(4):280-292.
81. Longo CJ, Fitch M, Deber RB, et al. Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer. 2006;14(11): 1077-1085.
82. Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22(4):745-755.
83. Sharp L, Timmons A. Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer. 2016;24(2):699-709.